Tue, 21-Oct-2025

Bayer’s argument to weedkiller is again rejected by the US Supreme Court

weedkiller

The U.S. Supreme Court rejected another bid by Bayer AG (BAYGn.DE) to dismiss litigation alleging that its Roundup weedkiller causes cancer. The justices turned away a Bayer appeal and left in place a lower court decision upholding an $87 million judgment. Roundup-related lawsuits have dogged Bayer since it acquired the brand in 2018. An appeals … Read more

Due to delayed cancer medicine, Bristol Myers will be sued for $6.4 billion

Bristol

A U.S. judge refuses to dismiss a $6.4 billion lawsuit against Bristol Myers Squibb. Trustee says drugmaker delayed cancer drug approval to avoid payments to shareholders. Former Celgene Corp was bought by Bristol Myers in 2019 for $80.3 billion. A U.S. judge on Friday would not excuse a $6.4 billion claim blaming Bristol Myers Squibb … Read more